Pfizer Inc. (NYSE:PFE) has been identified as one of the best low volatility large cap stocks to invest in, with a price target of $35. The acquisition of Metsera, Inc. is seen as a strategic move to tap into the obesity market after setbacks in oral GLP-1 programs. This acquisition positions Pfizer to lead in a high-growth therapeutic area and adds promising therapeutic candidates to its portfolio. Pfizer is a global biopharmaceutical company focused on wellness and cures. While PFE offers investment potential, some AI stocks may offer greater upside.

Read more at Yahoo Finance: Guggenheim Lifts PT on Pfizer Inc. (PFE) to $35 From $33, Keeps a Buy Rating